-The Hindu The question that must be asked, is whether India is willing to compromise on its laws and the safety and rights of its citizens to protect the business interests of reactor suppliers In 2010, under pressure from multinational nuclear suppliers, the Manmohan Singh government pushed through a law to protect them from the consequences of a nuclear accident. The law makes it impossible for victims to sue the supplier, even...

-The Hindu India ranks among the lowest in the world in public spending on health, but the private spending is one of the highest. The National Sample Survey Organisation’s report (2006) shows over 35 per cent of people who are hospitalised fall below the poverty line because of the expenses that follow, and over 40 per cent have to borrow or sell assets to pay for their care. Private sector provision...

-The Economic Times Chhattisgarh is set to become the first state to extend health insurance cover to all its unorganised sector workers, a step that will not only make healthcare accessible to all but also set a model for other states to follow. The state has offered to pay the insurance premium from October 1 for all those not covered under the Centre's flagship health insurance scheme-the Rashtriya Swasthya Bima Yojna (RSBY)....

-Inclusion.in There is good news. And there’s bad news. The good news first. There’s been a bumper wheat crop and the granaries are overflowing. And the bad news? Where do we begin? A lot of that grain will rot. Millions will still remain hungry. Heavily in debt and distressed, farmers are committing suicide. Food prices are soaring. There’s more… Farmers don’t have money. Their land is too small and isn’t yielding much. Fertilisers and...

India's use of the compulsory licensing provision under its patents law for the first time to make the patented cancer drug Nexavar available at affordable prices is an essential, although belated step to curb the mounting cost of drugs. The grant of the licence by the Controller-General of Patents, Designs and Trade Marks to Natco Pharma for manufacture of the drug Sorafenib Tosylate (Nexavar) to treat liver and kidney cancer is...